What is Chronic Kidney Disease?
Your kidney performs several important functions by maintaining the balance in the body, like:
- Removing waste products from the body
- Regulation of blood pressure
- Balancing important minerals in your body
- Keeping your bones healthy by converting vitamin D
- Producing important hormones
These functions not getting performed well is called kidney disease. Chronic kidney disease (CKD) is a long-term condition where the kidneys slowly lose their ability to work properly. It’s quite common, especially as people get older.1
Although there’s no cure, you can take steps to keep your kidneys working as long as possible.
Cardiovascular complications in CKD
CKD is divided into five stages, with stage G5 representing the most advanced form, known as kidney failure. All stages of CKD are associated with increased risks of cardiovascular morbidity, premature mortality, and/or decreased quality of life.2 CKD significantly increases the risk of developing cardiovascular complications, including coronary artery disease, stroke, heart failure, arrhythmias, and sudden cardiac death.3
In the early stages of CKD, common risk factors for heart disease are high blood pressure, diabetes, and high cholesterol. As CKD progresses to more advanced stages, other less common factors become more important. These include too much salt and fluid in the body, anaemia (low red blood cell count), ongoing inflammation, poor nutrition, overactive nerves, problems with bones and minerals, the build-up of harmful substances that the kidneys can no longer remove (called uremic toxins), and hormonal imbalances.
The pattern of heart disease in people with chronic kidney disease (especially in the most advanced stage, called end-stage renal failure or ESRF) is different from that in the general population. Instead of dying mainly from heart attacks, these patients are more likely to die suddenly and unexpectedly.4
Heart scans (echocardiograms) have shown that many people with ESRF have serious heart problems. These include:
- Thickening of the heart muscle (called left ventricular hypertrophy or LVH)
- Problems with how the heart pumps or relaxes
- An enlarged, weakened heart (known as dilated cardiomyopathy)
These heart issues are strongly linked to a poor outcome—more so than the usual risk factors like high blood pressure or high cholesterol. Even when doctors take into account whether a patient has blocked heart arteries, these heart changes still predict a higher risk of sudden death. This helps explain why sudden cardiac death is so common in people with advanced kidney disease.4
What is Left Atrial Enlargement?
The left atrium is one of the four chambers of the heart. It receives oxygen-rich blood from the lungs and sends it to the left ventricle, which then pumps it out to the rest of the body. Left Atrial Enlargement (LAE) means this chamber has become bigger than normal.
This enlargement usually happens because the heart has to work harder than usual, often due to:
High blood pressure
High blood pressure (Hypertension) is both a cause and a consequence of CKD. It plays a major role in the development and worsening of kidney problems. Due to narrowing and stiffness of blood vessels, the entire circulatory system gets under a lot of strain, including the tiny blood vessels in the kidneys, which help in filtering waste and extra fluid from the blood.6
The heart’s main pumping chamber, the left ventricle, can develop problems relaxing and filling with blood properly because of the extra stress from pumping blood to the body. This condition is called left ventricular diastolic dysfunction. Diastolic dysfunction is an early sign of heart problems in CKD and can eventually lead to heart failure with preserved ejection fraction (a type of heart failure where the heart pumps normally but fills poorly).
Stiffness of the heart6
Thickening of muscles of heart muscles is very common in CKD patients. It occurs as a result of both pressure overload and volume overload on the heart.
Pressure Overload
This happens when the heart has to pump against high resistance due to the narrowing of blood vessels. Blood vessels lose their elasticity (they become stiff), and there is vascular calcification (hardening due to calcium deposits).
Volume Overload
There are extra fluid buildups in the body because the kidneys are no longer able to remove fluids properly. As a result, the heart has to work harder to pump this additional volume of fluid, putting it under constant strain.
Anaemia
In CKD, the kidneys produce less erythropoietin, a hormone that helps make red blood cells. Fewer red blood cells mean less oxygen is carried in the blood. To compensate, the heart pumps faster and harder to deliver enough oxygen to the body. This creates a hyperdynamic state, where the heart is working overtime—even at rest.6
Electrolyte disturbances
In CKD, imbalances in calcium, phosphate, parathyroid hormone (PTH), and vitamin D are common and contribute to bone problems known as renal osteodystrophy. The kidneys produce less calcitriol (the active form of vitamin D), which leads to low calcium levels (hypocalcemia). It also fails to remove phosphate properly, causing high phosphate levels (hyperphosphatemia). Secondary hyperparathyroidism (overactivity of the parathyroid glands) often develops early in CKD, even before calcium or phosphate levels become abnormal. Therefore, monitoring PTH levels is important in moderate CKD.7
Other medical conditions
Several heart conditions—both congenital (present from birth) and acquired—can contribute to heart problems in people with chronic kidney disease (CKD). These include:5
- Aortic valve stenosis (narrowing of the aortic valve)
- Arteriovenous fistulas (abnormal connections between arteries and veins)
- Athlete’s heart (heart enlargement from intense training)
- Ventricular septal defect (a hole in the wall between heart chambers)
- Patent ductus arteriosus (persistent fetal blood vessel after birth)
- Mitral valve stenosis
- Mitral valve regurgitation (leaking mitral valve)
- Mass or tumour in the left atrium
In addition, diabetes can also contribute to many of these heart problems by affecting the heart muscle and blood vessels.
Why does LAE matter?
LAE is not just a structural change—it’s a warning sign. It increases the risk of:
- Irregular heartbeats like atrial fibrillation
- Stroke (due to blood clots that can form in the enlarged atrium)
- Heart failure
- Sudden cardiac death
So, LAE is another example of how CKD puts extra stress on the heart and contributes to serious cardiovascular complications.
What are the best ways to diagnose left atrial enlargement in CKD?
- Imaging modalities:1
- Transthoracic echocardiography (TTE)
- LA diameter vs. LA volume index (LAVI)
The gold standard for assessing LAE is transthoracic echocardiography (TTE). This non-invasive test provides real-time images of the heart, allowing precise measurement of the left atrial (LA) diameter. However, measuring LA volume index (LAVI)—which accounts for body size—is considered more accurate and reliable than simple diameter measurements, especially in early or borderline cases.
- Use of ECG findings:
Common ECG signs include prolonged P-wave duration, notched or biphasic P-waves, especially in lead II or V1. Although ECG is less sensitive than echocardiography, it remains a helpful initial or screening tool.
- Advanced imaging:
- Cardiac MRI for structural analysis, particularly when echocardiographic images are unclear or when precise measurements are essential for treatment planning.
- By biomarkers (e.g., NT-proBNP) as supportive tools, NT-proBNP can support the diagnosis, especially when LAE is due to diastolic dysfunction or heart failure.
What are management strategies?8
Rate Control:
- First-line approach: Rate control, using medications to slow the heart rate, is often the initial strategy for AFib in CKD patients. Beta-blockers and non-dihydropyridine calcium channel blockers are frequently used to manage heart rate. Additionally, medication dosages may need to be adjusted based on the level of kidney function
Rhythm Control:
- Rhythm control strategies: These aim to restore and maintain a normal sinus rhythm (the heart's natural rhythm) and may involve antiarrhythmic drugs (AADs) or procedures like cardioversion or ablation. The decision to pursue rhythm control can be complex in CKD patients, as some AADs may have limitations or risks associated with their use in those with kidney disease
- Cardioversion and ablation: Direct current cardioversion (DCCV) may be considered for symptomatic or recent-onset AFib, while ablation procedures are increasingly being used in advanced CKD, though evidence on outcomes is still being researched
Anticoagulation:
- Stroke prevention: Anticoagulation therapy is crucial to reduce the risk of stroke and systemic embolism in AFib patients, including those with CKD. Warfarin and direct oral anticoagulants (DOACs) like apixaban, dabigatran, and rivaroxaban are used for anticoagulation
- CKD and anticoagulation: The choice of anticoagulant and its dosage needs careful consideration, as some DOACs have specific recommendations or limitations in patients with varying degrees of kidney function. Mineralocorticoid receptor antagonists (like spironolactone): Help manage fluid retention, blood pressure, and heart-related complications in CKD
Some other ways to take steps to control worsening health condition,9
- Keep your blood pressure in a healthy range
- Address comorbid conditions like diabetes, dyslipidemia
- lifestyle changes
- maintain a healthy weight
- Eat less salt
- quit smoking
- manage stress
Summary
Chronic Kidney Disease (CKD) increases the risk of serious heart complications, including Left Atrial Enlargement (LAE). LAE in CKD arises due to hypertension, fluid overload, anaemia, and other metabolic disturbances. It significantly raises the risk of atrial fibrillation, stroke, heart failure, and sudden cardiac death. Diagnosis relies on echocardiography, ECG, and supportive biomarkers. Management includes heart rate/rhythm control, anticoagulation, and addressing contributing factors. Lifestyle modifications, controlling blood pressure, and managing comorbidities like diabetes are vital to slowing disease progression and improving outcomes. Early detection and comprehensive care are essential for preserving both kidney and cardiovascular health in CKD patients.
References
- ‘Chronic Kidney Disease’. Cleveland Clinic, Accessed 23 June 2025. Available from: https://my.clevelandclinic.org/health/diseases/15096-chronic-kidney-disease.
- Zoccali, Carmine, et al. ‘Cardiovascular Complications in Chronic Kidney Disease: A Review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association’. Cardiovascular Research, vol. 119, no. 11, May 2023, pp. 2017–32. PubMed Central, Available from: https://doi.org/10.1093/cvr/cvad083.
- Hill, Nathan R., et al. ‘Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis’. PloS One, vol. 11, no. 7, 2016, p. e0158765. PubMed, Available from: https://doi.org/10.1371/journal.pone.0158765.
- Stewart, Graham A., et al. ‘Electrocardiographic Abnormalities and Uremic Cardiomyopathy’. Kidney International, vol. 67, no. 1, Jan. 2005, pp. 217–26. PubMed, Available from: https://doi.org/10.1111/j.1523-1755.2005.00072.x.
- ‘Left Atrial Enlargement (LAE): Symptoms, Causes & Treatment’. Cleveland Clinic, Accessed 3 Jul. 2025. Available from: https://my.clevelandclinic.org/health/diseases/23967-left-atrial-enlargement.
- Taddei, Stefano, et al. ‘Hypertension, Left Ventricular Hypertrophy and Chronic Kidney Disease’. Heart Failure Reviews, vol. 16, no. 6, Nov. 2011, pp. 615–20. PubMed, Available from: https://doi.org/10.1007/s10741-010-9197-z.
- Chronic Kidney Disease - Genitourinary Disorders’. MSD Manual Professional Edition, Accessed 15 Jul. 2025. Available from: https://www.msdmanuals.com/professional/genitourinary-disorders/chronic-kidney-disease/chronic-kidney-disease.
- Potpara, Tatjana S., et al. ‘Management of Atrial Fibrillation in Patients with Chronic Kidney Disease in Europe Results of the European Heart Rhythm Association Survey’. EP Europace, vol. 17, no. 12, Dec. 2015, pp. 1862–67. DOI.org (Crossref), Available from: https://doi.org/10.1093/europace/euv416.
- ‘High Blood Pressure & Kidney Disease - NIDDK’. National Institute of Diabetes and Digestive and Kidney Diseases, Accessed 15 Jul. 2025. Available from: https://www.niddk.nih.gov/health-information/kidney-disease/high-blood-pressure.

